Women should be offered a choice of contraceptive methods and be informed of the advantages and disadvantages of each. Healthcare provider should give the woman information about ;
The information booklets below are issued in Public Interest by the makers of Silverline IUD. The booklets outline information and guidelines about the use of Silverline. These can be downloaded & circulated amongst women. You can also contact a representative from Pregna for more print material.
Users can also be guided to visit the website www.silverlineiud.com for more details
Expect changes in bleeding patterns and cramps after IUD placement. These symptoms reduce after several months of usage.
Silverline cannot be used in the following conditions:
Silverline is contraindicated in women with: known or suspected pregnancy, congenital or acquired uterine anomaly, Suspected Endometriosis or infected abortion in the past 3 months; unexplained uterine bleeding; current IUD; acute pelvic inflammatory disease (PID) or history of PID, genital tract infections
PID awareness is essential. IUDs have been associated with an increased risk of PID. PID is often associated with sexually transmitted infections (STIs); Silverline does not protect against STIs, including HIV.